Loring Wolcott & Coolidge Fiduciary Advisors LLP Dexcom Inc Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Dexcom Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 2,043 shares of DXCM stock, worth $130,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,043
Previous 2,043
-0.0%
Holding current value
$130,752
Previous $283,000
18.37%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DXCM
# of Institutions
1,125Shares Held
353MCall Options Held
4.19MPut Options Held
4.54M-
Vanguard Group Inc Valley Forge, PA44.6MShares$2.85 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY33.9MShares$2.17 Billion0.11% of portfolio
-
State Street Corp Boston, MA16.2MShares$1.04 Billion0.1% of portfolio
-
Baillie Gifford & CO15.3MShares$981 Million1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA13.4MShares$860 Million0.43% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $24.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...